Press
If you're writing about on-device AI in clinical software, the privacy posture of health-tech, or the failure modes of the cloud-scribe industry, here's what you need from us.
Reaching a human
Email press@bryl.app. We answer within one business day. We will get on a call. We do not require an embargo template; tell us your timeline and we'll match it.
Fast facts
| Product | Bryl — on-device therapy scribe for licensed psychotherapists |
| Publisher | Roushan, Inc. (Wilmington, DE) |
| Stage | Closed beta · Q3 2026 · 500 US clinicians |
| Platform | Universal — iOS 17+ on iPhone 13 and newer; iPadOS 17+ on iPad with M1 chip and newer |
| Pricing | Solo $29/mo · $190/yr · $299 lifetime · Practice $49/mo · $390/yr · $499 lifetime |
| Architecture | Audio, transcript, and note never leave the device that captured them. No Bryl server processes content. |
| Models | FluidAudio Parakeet TDT v3 with diarization (transcription) · Apple Foundation Models on iPhone 15 Pro+ or bundled Phi-4-mini Q4_K_M (drafting) · all on-device |
| Compliance | No BAA required because Bryl is not a Business Associate — see architectural attestation |
Brand assets
The brand mark is the lowercase wordmark bryl. with a Clay period — set in SF Pro Display Bold. The Clay disc is sized at 22% of the font height, baseline-aligned. Master SVG: bryl-appicon.svg. Long-form marketing wordmark: bryl-wordmark.svg.
- The mark is always lowercase. Body copy may use titlecase “Bryl”; the graphic mark never does.
- The Clay accent is
#B87E63. The Linen surface it sits on is#F8F1E5. - Do not pair the wordmark with additional decorative marks. The Clay period is the accent.
Photography
We don't do staged photography of clinicians. Privacy-by-architecture extends to imagery; we do not photograph therapists or clients even with releases. For abstract Linen-palette imagery suitable for layout, write to press@bryl.app and we will send you the source files.
Quotes you can use
“The architecture is the product. A BAA is paper that says we'll handle your patients' data carefully. We'd rather not handle it at all.”
— Rakesh Roushan, founder, Roushan, Inc.
What we will not do for a story
- We will not provide unredacted session recordings, transcripts, or notes — even ones we generated ourselves for testing. The architecture means we don't hold them.
- We will not connect you to closed-beta clinicians without their explicit, opt-in consent for a specific outlet.
- We will not run a press cycle that exaggerates capability we haven't shipped. If we've told you a feature is in Q4, it's in Q4 — not next month for the launch piece.